BioSyent Inc.
RX.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 11.99% | 7.27% | 10.83% | 13.36% | 33.13% |
| Total Depreciation and Amortization | 189.01% | 195.86% | 173.82% | -33.59% | -28.23% |
| Total Amortization of Deferred Charges | -53.61% | -92.74% | -95.38% | 370.52% | 276.72% |
| Total Other Non-Cash Items | 127.90% | 119.02% | 76.93% | -609.55% | -1,682.45% |
| Change in Net Operating Assets | 165.43% | -488.12% | 160.62% | -112.31% | -1,199.51% |
| Cash from Operations | 359.72% | -3.42% | 67.72% | 1.66% | -53.16% |
| Capital Expenditure | -17.68% | -9.33% | 11.42% | -303.49% | -126.73% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -136.62% | 1,572.56% | 332.97% | 411.77% | 63.25% |
| Cash from Investing | -154.10% | 1,623.66% | 260.20% | 343.89% | 62.69% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.44% | -5.45% | -5.29% | -5.24% | -5.75% |
| Issuance of Common Stock | 164.25% | 361.73% | 274.29% | -- | -- |
| Repurchase of Common Stock | -42.09% | -14.40% | -55.75% | 16.56% | 17.47% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -5.34% | -5.07% | -7.10% | -5.05% | -36.76% |
| Other Financing Activities | 15.16% | 14.48% | 13.45% | 12.87% | 12.21% |
| Cash from Financing | -21.27% | -4.56% | -32.38% | 11.39% | 5.86% |
| Foreign Exchange rate Adjustments | 96.32% | 106.68% | 115.29% | -253.23% | -190.76% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.90% | 480.67% | 2,577.84% | 105.92% | -20.25% |